Startup Capital

Startup funding options for selling, building, or scaling your venture

Siert Bruins Siert Bruins is the author of this webpage
where can you find your startup capital

For most inventors, money is not the starting point — the idea is where it all begins. Capital only becomes relevant when you want to move beyond thinking and start doing: building a prototype, testing the market, protecting intellectual property, or (trying to) turning an invention into a real business.

Startup capital is simply the fuel that allows you to move from one step to the next. Sometimes that fuel is modest and temporary. In other cases, it must last for years before real value is created. Understanding what capital is — and what it is not — helps you avoid raising money too early, too late, or in the wrong form.

This section explains how startup capital works in practice. It introduces the main types of funding, the logic behind them, and the situations in which they are typically used. The goal is not to push you toward funding, but to help you make informed decisions when capital becomes necessary.

Not every invention requires the same amount of capital. Some ideas can be explored with limited resources, while others demand significant investment long before they are ready for the market. The role of capital depends on what needs to happen next: reducing technical uncertainty, testing whether there is real demand, or building an organization that can deliver reliably. Understanding this helps founders avoid raising the wrong type of funding at the wrong moment.

The Two Core Forms of Startup Capital

Almost all startup financing eventually comes down to two fundamental forms: equity and debt. Understanding the difference early really matters, because it determines who carries the risk, who gets a say in important decisions, and who benefits if the startup succeeds. Understanding these instruments helps founders make informed choices and avoid common pitfalls. In the business world, the difference between equity and debt is second nature, but many university researchers and other people in salaried roles simply haven't needed to think about this before, which is completely understandable given their professional context. So nobody explains and I'll be honest: it took me quite a while to fully grasp how different equity and debt really are — especially coming from a research background. I think this is one of those situations many researchers recognise from conversations with business people or technology transfer officers: you sense that you don't fully understand the distinction, but it feels like something you are “supposed” to know. Asking the question seems slightly awkward, so you assume you more or less get it — and promise yourself to look it up later. Before we go any further, let me explain this distinction in plain language.

equity means you sell a piece of your company. A share is literally a portion of ownership. When an investor provides equity, they receive shares and become a co-owner: they participate in future profits, have a financial stake in growth, and may gain governance rights. Equity can feel like “free money”, but the cost is dilution — your ownership percentage decreases as more shares are issued. Importantly, equity investors also take on more risk: if the company fails, they typically lose their entire investment. On another page of this website you can find more information about raising equity to finance a startup.

Debt is different: it is borrowed money that must be repaid (usually with interest). Debt allows you to keep 100% ownership of your company, but it also creates fixed obligations — repayments that can put pressure on a young startup's cash flow. For lenders, the risk profile is much lower: they expect their money back with interest, and often require collateral or another form of security. If you fail to repay the loan, the lender has the right to take (or “seize”) the collateral to recover their funds. You should be aware that you must repay the money whether your startup succeeds or not. Debt financiers do not like risk — it is their money, it remains their money, and they want it back. Always. (Do you happen to own a nice house, Sir?) Because they are not buying a stake in your company, they rely entirely on your ability to repay — which is why debt financing is usually available only once you can show some traction, revenue, assets, or external guarantees that reduce the lender's risk. If you want to explore this type of funding in more detail, you can read more about borrowing money to fund your new business venture on another page of this website.

So, equity and debt affect control over the company. Equity investors can influence decisions because they own a share, while debt providers expect repayment but usually do not interfere in day-to-day operations. Choosing the wrong type of capital too early can dilute your ownership, restrict your freedom, or create repayment pressure that is hard to sustain.

Researchers and academic literature initially tend to skip over these distinctions because they focus on technical or scientific problems. Founders, however, face real consequences when they underestimate the practical implications of how their startup is funded.

The Investors Perspective

From an investor's perspective, an invention is not risky because it is new or ambitious. It is risky because several unknowns stack on top of each other. This acummulation is why investors are cautious, and why structure often matters as much as the brilliance of an invention.

This logic is explained in more detail in the overview of how investors think .

Startup capital is not a goal in itself. It is a practical tool that helps you move an invention forward when thinking alone is no longer enough. Whether you are validating technology, testing market demand, or building a company around your idea, capital simply enables the next step.

The key is not to raise as much money as possible, but to use the right form of capital at the right moment. That choice affects who shares the risk, who influences decisions, and how much freedom you retain as a founder. Understanding these differences early helps you avoid unnecessary complexity and irreversible mistakes later on.

You do not need to master all of this at once. Most founders encounter these topics gradually, often later than they expected. The purpose of this section is to give you a clear mental map, so that when capital becomes relevant for your invention or startup, you know where you are — and which direction makes sense to explore next.

About Siert Bruins

Siert Bruins, PhD

Hello! I'm Siert Bruins, a Dutch entrepreneur and founder of Life2Ledger B.V. . Trained as a Medical Biologist, I hold a PhD in Clinical Diagnostics from the University of Groningen and have over two decades of hands-on experience in innovation at the intersection of universities, hospitals and technology-driven companies.

Throughout my career, I have (co)-founded several life science startups and helped researchers, inventors, and early-stage founders transform their ideas into prototypes, patents, partnerships, and funded projects. My work spans medical device development, clinical validation, startup strategy, and technology transfer. I've guided innovations from the initial sketch to licensing agreements and investment negotiations.

Since 2009, I've run the Dutch version of this site. I launched to provide founders worldwide with practical, experience-based guidance on inventions, patents, valuation and raising startup capital. Today, in Life2Ledger, I also focus on blockchain-based data validation for AI in healthcare — Specifically: how can you be sure that your AI is trained and validated on the correct data, and that this data truly comes from the patient and the device you think it does?

I write everything on this website myself, based on real cases, real negotiations and real outcomes. No content farms. No generic AI text. Just practical guidance from someone who has been in the room.

Want to connect? Visit my LinkedIn or follow me on X. Have questions about your startup strategy or patents? Reach out and I'll share practical insights from real-world experience.